GleamWall
中文EN

EW Edwards Lifesciences Corp

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1099800 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.4%
TTM net income YoY-25.3%
TTM EPS YoY-23.7%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR-10.6%

Margins

Gross margin78.0%
Operating margin21.6%
Net margin15.3%
FCF margin21.3%
EBITDA margin24.2%

Returns

ROE9.7%
ROA7.5%
ROIC (approx.)12.1%
Asset turnover0.49x

Leverage & solvency

Liabilities / assets22.5%
Debt / equity0.06x
Current ratio4.60x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.68x
Accruals ratio-5.1%
Payout ratio—
Capex / revenue4.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$1.72B$1.74B$1.65B$1.57B$1.55B$1.53B$1.41B$1.39B
Cost of revenue$369.20M$392.40M$362.60M$343.00M$345.20M$344.40M$301.60M$292.20M
Gross profit$1.35B$1.35B$1.29B$1.23B$1.21B$1.19B$1.11B$1.09B
R&D expense$281.40M$278.90M$263.30M$267.70M$280.70M$276.20M$254.60M$271.10M
SG&A expense$560.90M$561.20M$522.20M$602.90M$514.60M$502.00M$465.70M$491.90M
Operating income$299.10M$513.20M$477.60M$151.10M$307.10M$411.20M$394.80M$312.60M
Pretax income$363.20M$519.80M$459.00M$90.40M$348.40M$400.20M$433.90M$390.10M
Income tax$61.80M$278.40M$78.30M$26.20M$56.10M$64.30M$70.30M$45.10M
Net income$307.50M$241.90M$380.70M$91.20M$291.10M$333.20M$358.00M$385.60M
EBITDA$344.00M$555.90M$518.50M$193.80M$346.30M$449.30M$431.40M$355.20M
EPS (basic)0.530.420.66—0.500.570.610.65
EPS (diluted)0.530.420.66—0.500.560.610.65
Weighted avg. shares (diluted)577.60M577.60M580.70M—585.70M587.90M587.80M—
Banking
Net interest income$36.50M$30.00M$33.50M-$132.90M$38.60M$37.40M$36.50M-$76.10M
Balance sheet
Cash & equivalents$3.11B$2.91B$2.45B$2.94B$2.69B$3.29B$3.15B$3.06B
Short-term investments$1.53B$1.35B$1.23B$1.29B$1.16B$789.40M$757.90M$930.70M
Receivables$784.90M$770.40M$775.70M$659.60M$693.30M$697.00M$669.20M$609.10M
Inventory$1.16B$1.13B$1.12B$1.13B$1.14B$1.14B$1.11B$1.09B
Current assets$7.25B$6.82B$6.23B$6.74B$6.36B$6.58B$6.21B$6.29B
PP&E, net$1.86B$1.84B$1.82B$1.81B$1.74B$1.73B$1.70B$1.69B
Goodwill$1.95B$1.95B$1.82B$1.77B$1.77B$1.78B$1.78B$1.78B
Intangibles$1.16B$1.38B$1.23B$1.13B$1.13B$1.17B$1.17B$1.18B
Total assets$14.14B$13.87B$13.32B$13.70B$13.27B$13.49B$13.02B$13.06B
Current liabilities$1.58B$1.51B$1.41B$1.81B$1.59B$1.40B$1.39B$1.51B
Long-term debt$598.80M$598.70M$598.50M$598.30M$598.20M$598.00M$597.80M$597.70M
Total debt$598.80M$598.70M$598.50M$598.30M$598.20M$598.00M$597.80M$597.70M
Total liabilities$3.18B$3.14B$2.99B$3.36B$3.07B$2.88B$2.83B$2.99B
Shareholders' equity$10.86B$10.62B$10.33B$10.34B$10.21B$10.55B$10.13B$10.00B
Net debt-$2.51B-$2.31B-$1.85B-$2.34B-$2.10B-$2.69B-$2.55B-$2.46B
Shares outstanding575.60M576.60M577.00M580.70M580.70M587.90M586.20M588.60M
Cash flow statement
Operating cash flow$570.30M$651.90M$43.80M$450.90M$573.70M$290.20M$280.40M-$127.50M
Capital expenditure$63.60M$66.90M$64.90M$97.40M$57.50M$49.30M$56.00M$49.80M
Free cash flow$506.70M$585.00M-$21.10M$353.50M$516.20M$240.90M$224.40M-$177.30M
Investing cash flow-$256.40M-$193.20M-$92.80M-$198.30M-$427.80M-$172.10M$85.30M-$576.70M
Financing cash flow-$100.80M-$300,000-$451.20M-$11.40M-$740.10M$52.70M-$258.00M$28.60M
Depreciation & amortization$44.90M$42.70M$40.90M$42.70M$39.20M$38.10M$36.60M$42.60M
Stock-based compensation$46.00M$42.20M$45.40M$39.20M$41.10M$37.50M$40.20M$31.70M
Share buybacks$138.90M$153.30M$421.80M$40.60M$588.70M$5.50M$258.60M$100.10M

Free plan shows the latest 8 periods; Pro shows all 71 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.